| # | Drug | Count |
|---|---|---|
| 0 | CAPECITABINE | 4 |
| 1 | METOCLOPRAMIDE | 4 |
| 2 | METOCLOPRAMIDE HYDROCHLORIDE | 4 |
| 3 | PREDNISOLONE | 4 |
| 4 | PREDNISOLONE ORAL | 4 |
| 5 | PREDNISOLONE ORAL SOLUTION | 4 |
| 6 | ADO-TRASTUZUMAB EMTANSINE | 3 |
| 7 | AMLODIPINE | 3 |
| 8 | FENTANYL | 3 |
| 9 | IBRUTINIB | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MIRVETUXIMAB SORAVTANSINE | 1 | 0.0006 |
| 1 | VINORELBINE | 3 | 0.0004 |
| 2 | ADO-TRASTUZUMAB EMTANSINE | 3 | 0.0004 |
| 3 | BINIMETINIB | 2 | 0.0003 |
| 4 | ENCORAFENIB | 2 | 0.0002 |
| 5 | LAPATINIB | 3 | 0.0002 |
| 6 | SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE | 1 | 0.0001 |
| 7 | GEFITINIB | 1 | 0.0001 |
| 8 | PERTUZUMAB | 3 | 0.0001 |
| 9 | TAPENTADOL HYDROCHLORIDE | 3 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vitamin D3 Analog [EPC] | 1 | 0.0000 |
| 1 | BCL-2 Inhibitor [EPC] | 3 | 0.0000 |
| 2 | HER2/neu Receptor Antagonist [EPC] | 3 | 0.0000 |
| 3 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 3 | 0.0000 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 6 | 0.0000 |
| 5 | CTLA-4-directed Blocking Antibody [EPC] | 1 | 0.0000 |
| 6 | Topoisomerase Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Nitrate Vasodilator [EPC] | 1 | 0.0000 |
| 8 | Opioid Agonist [EPC] | 3 | 0.0000 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 3 | 0.0000 |